Brief: Addex: ADX71149 Receives IND Approval To Start Phase 2a Clinical Study In Epilepsy

Addex Therapeutics

21/01/2021 06:10

Jan 21 (Reuters) - ADDEX THERAPEUTICS LTD  ADXN.S :
    * REG-ADDEX ADX71149 RECEIVES IND APPROVAL TO START A PHASE
2A
CLINICAL STUDY IN EPILEPSY
    * ADDEX THERAPEUTICS LTD - FIRST PATIENT IS EXPECTED TO BE
TREATED
DURING Q2 2021.

Source text for Eikon:  ID:nGNE4YFbFB 
Further company coverage:  ADXN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))